<DOC>
	<DOC>NCT00617994</DOC>
	<brief_summary>This will be an open label study of INCB018424 topical cream applied to 2 - 20% BSA in patients with active, stable plaque psoriasis.</brief_summary>
	<brief_title>Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects must have psoriatic lesions measuring protocol specific BSA Lesions solely involving the palms of the hands, the soles of the feet, the intertriginious areas, the scalp or the face Pustular psoriasis or erythroderma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>psoriasis</keyword>
</DOC>